Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) Meeting Abstract
| Authors: | Dunn, L.; Ho, A. L.; Haque, S.; Fury, M. G.; Baxi, S. S.; Cullen, G.; Pfister, D. G.; Sherman, E. J. |
| Abstract Title: | Assessment of second-line VEGF-inhibitor therapy in radioiodine-refractory (RAIR) differentiated thyroid cancer (DTC) |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036903442 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.e17064 |
| Notes: | Meeting Abstract: e17064 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
